The successful treatment for cardiac tamponade during radiofrequency ablation of hepatocellular carcinoma
Chen Xue a , b , Zhigang Ren a , b , Xiaobo Hu a , b , Yuting He a , b , Ranran Sun a , b , Juan Li a , b , Guangying Cui a , b , Zujiang Yu a , b , ∗
a Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou 450052, China
b Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
∗ Corresponding author at: Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou 450052, China.
E-mail address: johnyuem@zzu.edu.cn (Z. Yu).
Abstract：Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide [1] . Repeated liver resection remains a valid and safe curative therapy option for recurrent HCC in a minority of patients, because of multifocal intrahepatic or extra-hepatic recurrence and tumors in unresectable locations [2] . HCC nodules less than 3 cm located in the hepatic dome beneath the diaphragm may represent one of the most difficult sites for resection [3] . Therefore, some local invasive therapies, such as radiofrequency ablation (RFA), microwave ablation, transarterial chemoembolization (TACE) and laser hyperthermia, have been developed and applied in clinical HCC treatment [4] . RFA has high frequency energy which heats the surrounding tissues and causes severe complications such as acute massive hemorrhage, thermal injury to viscera, pneumothorax and cardiac tamponade [5] .
引用本文:
. [J]. Hepatobiliary Pancreat Dis Int, 2019, 18(1): 90-92.
Xue C, Ren Z, Hu X, He Y, Sun R, Li J, Cui G, Yu Z. The successful treatment for cardiac tamponade during radiofrequency ablation of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int, 2019, 18(1): 90-92.
2019, Vol. 18 
